883 related articles for article (PubMed ID: 4615664)
21. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
22. [Growth kinetics of B-16 melanoma].
Vasil'eva LS; Bogdanov GN; Konovalova NP
Izv Akad Nauk SSSR Biol; 1974; (2):299-300. PubMed ID: 4461753
[No Abstract] [Full Text] [Related]
23. Clonogenic cell survival curves for human melanoma xenografts using agar diffusion chamber and lung colony assays.
Selby PJ; Thomas JM
Br J Cancer Suppl; 1980 Apr; 4():150-3. PubMed ID: 6932919
[TBL] [Abstract][Full Text] [Related]
24. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line.
Montgomery AM; Mueller BM; Reisfeld RA; Taylor SM; DeClerck YA
Cancer Res; 1994 Oct; 54(20):5467-73. PubMed ID: 7923181
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
[TBL] [Abstract][Full Text] [Related]
26. In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
Gibson MH; Bertalanffy FD
J Natl Cancer Inst; 1972 Oct; 49(4):1007-18. PubMed ID: 5084119
[No Abstract] [Full Text] [Related]
27. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice.
Huang S; DeGuzman A; Bucana CD; Fidler IJ
Clin Cancer Res; 2000 Jun; 6(6):2573-81. PubMed ID: 10873114
[TBL] [Abstract][Full Text] [Related]
28. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN
J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
[TBL] [Abstract][Full Text] [Related]
29. Development of a new melanoma model in C57BL/6 mice.
Berkelhammer J; Oxenhandler RW; Hook RR; Hennessy JM
Cancer Res; 1982 Aug; 42(8):3157-63. PubMed ID: 7093959
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of melanoma growth and metastasis by ATF2-derived peptides.
Bhoumik A; Gangi L; Ronai Z
Cancer Res; 2004 Nov; 64(22):8222-30. PubMed ID: 15548688
[TBL] [Abstract][Full Text] [Related]
31. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
32. Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis.
Fodstad O; Kjønniksen I
J Cell Biochem; 1994 Sep; 56(1):23-8. PubMed ID: 7806588
[TBL] [Abstract][Full Text] [Related]
33. [Quantitative aspect of the phenomenon of tumor growth inhibition in the newborn].
Karmanova NV; Chertkova AI; Svet-Moldavskiĭ GIa
Vestn Akad Med Nauk SSSR; 1979; (12):40-9. PubMed ID: 516885
[No Abstract] [Full Text] [Related]
34. [Cytological and cytochemical characteristics of cultured melanoma B 16 cells].
Bassleer R; Rustin P; Lepoint A; Goessens G; Heinen E
Arch Biol (Liege); 1975; 86(4):423-33. PubMed ID: 1233921
[No Abstract] [Full Text] [Related]
35. Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.
de Lorenzo MS; Ripoll GV; Yoshiji H; Yamazaki M; Thorgeirsson UP; Alonso DF; Gomez DE
In Vivo; 2003; 17(1):45-50. PubMed ID: 12655789
[TBL] [Abstract][Full Text] [Related]
36. The in vivo cell kinetics of transplantable B16 mouse melanoma.
Gibson MH; Bertalanffy FD
Growth; 1972 Dec; 36(4):263-74. PubMed ID: 4653610
[No Abstract] [Full Text] [Related]
37. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of the mechanism of glucocorticoid enhancement of experimental metastasis.
Fidler IJ; Lieber S
Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):607-13. PubMed ID: 4638595
[No Abstract] [Full Text] [Related]
39. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
Burg MA; Grako KA; Stallcup WB
J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527
[TBL] [Abstract][Full Text] [Related]
40. [Erythroid differentiation and specific protein synthesis by the leukemic cell line K-562 (under in-vivo cultivation conditions)].
Bil'ko NM; Korobov VN; Bebeshko VG; Starodub NF
Tsitol Genet; 1995; 29(5):65-71. PubMed ID: 8721849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
